Sanofi India Limited has officially received approval from the Central Government for the appointment of Mr. Deepak Arora as the company’s Managing Director. The appointment is effective for a tenure of three years, commencing from October 27, 2025. This regulatory green light confirms the leadership transition following the company’s previous disclosures regarding the executive’s appointment.
Formalizing Executive Leadership
Following the submission of necessary applications, Sanofi India Limited has confirmed that the Central Government has approved the appointment of Mr. Deepak Arora as the Managing Director. The term of this appointment is set for three years, running from October 27, 2025, through October 26, 2028. The official communication from the Ministry of Corporate Affairs was received by the company on April 1, 2026.
Terms of Appointment
The appointment is subject to specific administrative requirements set forth by the Ministry. Mr. Deepak Arora is required to provide a formal undertaking to the company confirming that he will not hold interests in any selling agencies of the firm during his tenure without prior government authorization. Additionally, the mandate stipulates that the Managing Director’s headquarters must be established in the city where he resides to fulfill his professional duties.
Operational Continuity
This leadership confirmation ensures stability for Sanofi India as it continues its operations. The approval has been granted under the provisions of the Companies Act, 2013, and remains in effect without prejudice to any future changes in government policy or legislative amendments. This milestone concludes the procedural appointment process initiated by the company in late 2025.
Source: BSE
